Home

Articles from Allegro NV; American Regent

Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million
                                                                                                   
By Allegro NV; American Regent · Via GlobeNewswire · November 25, 2025